Pnc Financial Services Group, Inc. Monte Rosa Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 66 shares of GLUE stock, worth $323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66
Previous 28
135.71%
Holding current value
$323
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GLUE
# of Institutions
107Shares Held
53.4MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$37.7 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$32.6 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$27.7 Million1.15% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$27.7 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$24.1 Million0.27% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $229M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...